Prenatal RSVpreF Vaccination Uptake Associated with Non-English Primary Language During Its First Season at a Federally Qualified Health Center
RSV and bronchiolitis are major causes of hospitalizations and death among infants. The RSVpreF vaccine was approved and released in 2023 for pregnant women to prevent severe RSV in infants during their first RSV season. This is the first prenatal vaccine recommended since the COVID-19 vaccine was approved. Howev...